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Methylmercury is as an environmental pollutant a dose of 0.2 mmol/kg. On the other hand, secretion of which produces several neurological disorders in man substantial amounts of selenium was observed when (1, 2) . Although many studies of the fate of methylmerbiliary secretion of mercury was depressed. When the cury in animals have been performed, the mechanisms concentration of selenium in the bile was higher than regulation of tissue distribution and excretion of meth-5 nmol/ml, biliary secretion of mercury was markedly ylmercury have not been examined in detail. Enterodepressed independently of the dose of methyl merhepatic circulation of methylmercury is considered to cury administered (1 mmol/kg or 10 mmol/kg). These play an important role in metabolism and toxicity of results suggest that the degree of inhibitory effect of methylmercury, because a considerable amount of selenite may be determined by the selenium concenmethylmercury is secreted into the bile most of which tration in the liver or the bile after treatment with selenite rather than the molar ratio of the dose of is reabsorbed through the intestine (3). The main form methyl mercury and selenite. We concluded that the of methylmercury observed in the bile of animals is decrease in biliary secretion of methyl mercury in-present as a complex with glutathione (GSH) (4-7). duced by selenite may result from inhibition of path-Depletion of hepatic GSH significantly decreased the way for secretion of methyl mercury from liver to bile biliary secretion of both GSH and methylmercury (8, rather than the direct formation of a compex between 9). The biliary secretion of methylmercury may be demethyl mercury and selenium. Methyl mercury has termined by the rate of secretion of GSH into the bile been considered to be secreted from liver to bile as a (8) . On the other hand, the biliary secretion of methylcomplex with glutathione (GSH). However, adminis-mercury is strongly inhibited by selenium-containing tration of selenite did not affect biliary secretion of compounds (10) . However, the mechanism of this effect GSH or hepatic glutathione S-transferase activity. has not been elucidated. Selenium compounds have Moreover, gel filtration of liver cytosol demonstrated been shown to reduce the toxicity of methylmercury that the distribution pattern of hepatic methyl mer- (11, 12) and to modify its tissue distribution (13-15).
cury between macromolecules and GSH was not sig-
The effects of selenium compounds on the toxicity and nificantly changed by administration of selenite.
tissue distribution of methylmercury might be due to These results suggest that selenite does not affect comdirect interaction of both compounds in animals to form plex formation of methyl mercury with GSH at least a complex of methylmercury and selenium (15, 16) . The present study was performed to examine the involve- 1 To whom all correspondence should be addressed at Department ment of the direct interaction of methylmercury and (DCNB) as substrates (19) . Protein concentration was determined
MATERIALS AND METHODS
by the method of Lowry et al. (20 Se]-Sodium selenite (5.6 Ci/g) was purchased from Amersham was homogenized in 3 volumes of ice-cold phosphate buffered saline Japan Co. Ltd. All other chemicals used for the experiments were and then the homogenate was centrifuged at 105,000 1 g at 4 ЊC for commercially obtained.
60 min. The supernatants (4 ml) were applied to a Sephadex G-15 column (25 mm 1 450 mm) and eluted with 50 mM Tris-HCl buffer Bile collection. Male Wistar rats weighing 180-220 g were pur-(pH 7.6) containing 1 mM EDTA and 0.5 M NaCl. The eluate was chased from Charles River Japan, Ind. The animals were anesthefractionated into 2 ml portions and the concentration of 203 Hg in each tized with sodium pentobarbital (100 mg/kg, with additional adminfraction was determined. istration if necessary) and body temperature was maintained constant by means of infrared lamps throughout the experiments. Bile ducts were cannulated with polyethylene tubing (id, 0.5 mm; od, 0.8
RESULTS mm). Then, various doses of [
75 Se]-sodium selenite (0.025-2.0 mmol/ 1.5 mCi/kg) were injected intravenously 2 hr after i.v. administration tered rats at a dose of 1 mmol/kg, the biliary secretion Determination of GSH. Bile samples were collected in ice-chilled of mercury was significantly decreased by administratubes containing EDTA (final concentration; about 100 mM) to pre-tion of selenite at a dose of 0.05 mmol/kg (one-twentieth vent oxidation of GSH in bile. Concentrations of GSH, cysteinylglycof the dose of methylmercury) and at doses more than ine (CysGly) and cysteine (Cys) in bile were determined by high 0.05 mmol/kg (Fig. 1) . In rats given 10 mmol/kg of methperformance liquid chromatography (HPLC) using ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulphonate (SBD-F) as a fluorogenic ylmercury, marked depression of biliary secretion of reagent according to our modification (6) of the method of Toyo'oka mercury was observed even when selenite was injected et al. (18) .
at a dose of 0.2 mmol/kg (one-fiftieth of the dose of methEnzyme assay. The liver was homogenized in 4 volumes of iceylmercury) (Fig. 2) . These results indicated that a spe- Moreover, as shown in Figs. 1 and 2 , secretion of sub-formation of a complex between methylmercury and selenium. stantial amounts of selenium was observed when biliary secretion of mercury was depressed. Figure 3 illusMethylmercury has been considered to be secreted from liver to bile as a complex with GSH (8, 21). Treattrates the relationship between the biliary concentration of mercury and selenium until 4 hr after injection ment of animals with GSH-depleting agents decreases hepatic GSH concentration and biliary secretion of both of selenite. When the concentration of selenium in the bile was higher than 5 nmol/ml, biliary secretion of methylmercury and GSH (9, 22). Figure 4 shows the effects of selenite on secretion of GSH and other thiol mercury was markedly depressed regardless of the dose of methylmercury and concentration of mercury compound into the bile of rats. Concentrations of GSH, CysGly and cysteine were not significantly influenced in the bile. These results suggest that the decrease in biliary secretion of methylmercury induced by selenite by administration of selenite.
Inhibition of biliary secretion of methylmercury by may result from inhibition of the pathway for secretion of methylmercury from liver to bile rather than the administration of an inhibitor for GST has also been
FIG. 3.
Relation between mercury and selenium concentrations in bile of rat treated with methylmercury and selenite. Various doses of selenite were administered 2 hr after administration of methylmercury (see Figs. 1 and 2 ). Rats received methylmercury at doses of 1 mmol/kg (A) or 10 mmol/kg (B).
DISCUSSION
Administration of sodium selenite at non-toxic doses strongly inhibited the secretion of methylmercury into bile ( Figs. 1 and 2) . Selenium compounds interact with methylmercury and modify its tissue distribution in animals (13, 15, 24). Selenium and methylmercury can directly react in animal tissue and form bis(methylmercuric) selenide (15, 16) . This complex formation of methylmercury and selenium after administration of selenium compounds may result in modification of the fate of methylmercury in animals. Therefore, we examined the involvement of the interaction of methylmercury and selenium in the inhibitory effect of selenite  FIG. 4 . Concentration of GSH and related thiol compounds in on the biliary secretion of methylmercury. As bis(methbile of rats after injection of selenite. Rats were injected with selenite ylmercuric) selenide is unstable and determination of (0.2 mmol/kg) 2 hr after treatment with methylmercury (1 mmol/kg). tissue concentration of this compound is difficult, a kiTotal: sum of GSH, CysGly and Cys.
netic study was performed. The results indicated that the extent of the inhibitory effect of selenite on biliary secretion of methylmercury is dependent on the dose reported (23) . It is possible that GST may be involved of selenite and the concentration of selenium in bile, in formation of complex of GSH with methylmercury. but not the molar ratio of methylmercury and selenite GST exists in multiple molecular forms in rat liver, administered ( Figs. 1 and 2 ). The inhibition of biliary and most GST isoenzymes are active toward either secretion of methylmercury was observed when sele-CDNB or DCNB (19) . Thus, we determined GST activ-nite was administered at the dose of one-fifties of the ity in the liver of rats using DCNB and CDNB as sub-dose of methylmercury (Fig. 2) . Moreover, selenite adstrates, and no significant effect of selenite on the GST ministration did not significantly affect the hepatic acactivity was observed (Table 1) . Moreover, gel filtration cumulation of methylmercury under the experimental of methylmercury in the liver cytosol at 30 min after conditions used in the present study (Table 2) . These administration of selenite demonstrated that the dis-results suggested that the inhibition of biliary secretion tribution pattern of hepatic methylmercury between of methylmercury induced by selenite may result from macromolecules and GSH was not significantly the effects of selenium on the pathway of hepatobiliary changed by treatment of rats with selenite (Fig. 5) . transport of methylmercury rather than interaction These results suggest that selenite does not affect com-with methylmercury. plex formation of methylmercury with GSH at least in Methylmercury has been considered to be secreted the liver. from liver to bile as a complex with GSH (8, 21) . Some Finally, we examined the possibility that administra-reagents which decrease methylmercury secretion into tion of selenite decreases accumulation of methylmer-bile have been reported. GSH-depleting agents such cury into the liver. However, methylmercury concen-as diethylmaleate (9) and inhibitors of hepatobiliary tration in the liver was not significantly decreased by transport of GSH such as ICG (21) decreased biliary secretion of not only methylmercury but also GSH. On administration of selenite as shown in Table 2 . Rats were treated with selenite (0.2 mmol/kg) 2hr after methylmercury (1 mmol/kg) administration. Each value represents the mean { S.D. of 3 Ç 6 animals. the other hand, S-methylcysteine, an inhibitor of GST, gates into the bile (26, 27) . Dutczak and Ballatori (28) reported that methylmercury-GSH complex was not a decreased biliary secretion of methylmercury without affecting the secretion of GSH into bile (23) . In the substrate for the canalicular glutathione S-conjugate
carriers, but appears to be a substrate for canalicular present study, selenite significantly decreased the biliary secretion of methylmercury ( Figs. 1 and 2 ), but did carriers that transport GSH. Selenium may specifically inhibit the activity of the canalicular transporter(s) innot affect that of GSH (Fig. 4) or hepatic GST activity (Table 1 ). These results indicated that selenite is a volved in active transport of GSH from liver to bile. novel inhibitor of the secretion of methylmercury into bile.
